Archive
Dec 15, 2010
Metabolic disease alliance with MedImmune
Nov 23, 2010
Collaboration on neurological disease target with Merck KGaA
Nov 11, 2010
Accelerated Positive Trend on Evotec's Revenues and Profits
Oct 28, 2010
License and collaboration agreement with Jingxin Pharma for EVT 201
Oct 27, 2010
Pain Alliance with APEIRON Biologics
Oct 05, 2010
Evotec and Shionogi Enter Fragment-based Drug Discovery Alliance
Sep 23, 2010
Ion Channel Hit Identification Agreement with Almirall
Sep 02, 2010
Evotec Completes Acquisition of DeveloGen
Aug 12, 2010
Strong Milestone Income Leads to Profitable 1st Half
Aug 04, 2010
Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim received
Jul 14, 2010
Evotec acquires DeveloGen
Jul 01, 2010
EVT 101 Phase II study started
Jun 17, 2010
First Milestone in Oncology Programme with Boehringer Ingelheim
May 19, 2010
Clinical Trial Milestone achieved
May 12, 2010
Evotec's Drug Discovery Business Set for Strong Growth
May 10, 2010
Integrated Drug Discovery Alliance with Genentech
Apr 27, 2010
Research Grant for H3 Receptor Antagonist Programme
Mar 25, 2010
2009 Results: Significant Step towards Sustainability
Mar 23, 2010
M&A Advisor Global Healthcare Turnaround Company of the Year
Mar 18, 2010
Agreement with Hypha Discovery to Further Enhance Lead Identification Platform
Mar 11, 2010
High Throughput Screening Agreement with Active Biotech
Mar 10, 2010
Good Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche
Feb 25, 2010
Evotec Extends and Broadens Research Agreement with Cubist Pharmaceuticals
Feb 02, 2010
Evotec and Vifor Pharma Sign Major Cooperation Agreement
Jan 14, 2010
Evotec and CHDI Foundation, Inc. Extend Collaboration to Fight Huntington's Disease
